Cited 0 time in
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis (vol 78, pg 383, 2022)
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Hong-Bae | - |
| dc.contributor.author | Kim, Jung-Ha | - |
| dc.contributor.author | Wolf, Bethany J. | - |
| dc.date.accessioned | 2024-12-20T07:55:27Z | - |
| dc.date.available | 2024-12-20T07:55:27Z | - |
| dc.date.issued | 2022-08 | - |
| dc.identifier.issn | 0031-6970 | - |
| dc.identifier.issn | 1432-1041 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/203882 | - |
| dc.description.abstract | In method section of abstract, line 3, hazard ratio (HR) should be replaced by odds ratio/relative risk (OR/RR). In addition, HR should be replaced by OR/RR in the results section of abstract, line 2 & 4. In ‘Data extraction and assessment of methodological quality’ section of Methods, line 7, OR should be replaced by odds ratio/relative risk (OR/RR). In addition, in ‘Data synthesis and statistical analysis’, line 13 & 16, HRs (hazard ratio) should be replaced by OR/RR. HR should be also replaced by OR/RR in method section, line 3 & 5, page 385. All HR in the results section should be replaced by OR/RR. All HR in Fig. 1 & 2 and table 1 & 2 should be replaced by OR/RR. All HR in supplemental table 2, 5 and supplemental Fig. 2,3, & 4 also should be replaced by OR/RR. | - |
| dc.format.extent | 1 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Springer Verlag | - |
| dc.title | Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis (vol 78, pg 383, 2022) | - |
| dc.type | Article | - |
| dc.publisher.location | 독일 | - |
| dc.identifier.doi | 10.1007/s00228-022-03335-w | - |
| dc.identifier.scopusid | 2-s2.0-85130187477 | - |
| dc.identifier.wosid | 000796344900001 | - |
| dc.identifier.bibliographicCitation | European Journal of Clinical Pharmacology, v.78, no.8, pp 1361 - 1361 | - |
| dc.citation.title | European Journal of Clinical Pharmacology | - |
| dc.citation.volume | 78 | - |
| dc.citation.number | 8 | - |
| dc.citation.startPage | 1361 | - |
| dc.citation.endPage | 1361 | - |
| dc.type.docType | Correction; Early Access | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | erratum | - |
| dc.identifier.url | https://link.springer.com/article/10.1007/s00228-022-03335-w | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
